|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
| 55961 | EORTC 55961,Phase II study on Paclitaxel in recurrent uterine papillary serous carcinoma (UPSC) |
| 55005 | A randomized phase III study comparing Gemcitabine plus Carboplatin versus Carboplatin monotherapy in patients with advanced eepithelial ovarian carcinoma who failed first-line platinum based therapy Intergroup AGO-EORTC-NCIC CTG trial (EORTC 55005) |
| 55963 | A randomized phase III study for the treatment of recurrent epithelial ovarian cancer: Chemotherapy alone versus chemotherapy followed by secondary cytoreductive surgery in patients with a treatment-free interval of more than 12 months-trial 55963 |
| 55962 | A randomized phase III trial for evaluation of usefullness of pelvic drains after radical hysterectomy and node dissection (RHND) |
| 55954 | A randomized phase III study of chemotherapy and radiotherapy versus radiotherapy alone as adjuvant treatment to patients with node positive stages Ib or IIa cervix cancer (EO ORTC/NSGO/COSA/MRC intergroup trial) |
| 55951 | Taxol or Oxaliplatin in platinum-pretreated advanced ovarian cancer patients |
| 55931 | EORTC-NCIC-Scottish-Scandinavian-Intergroup phase III comparison of a combination of Taxol-platinum and a combination of cyclophosphamide-platinum chemotherapy in the treatment of advanced epithelial ovarian cancer |
| 55842 | Phase II trial of 4'-epiDoxorubicin in disseminated carcinoma of the uterine cervix |
| 55923 | Phase II study of Cisplatin, Doxorubicin, and Ifosfamide in carcinosarcoma (malignant mixed mesodermal tumors) of the female genital tract |
| 55904 | Phase III study to evaluate platinum based chemotherapy as an adjuvant to surgery in early ovarian cancer patients |
| 55883 | Phase II study of Navelbine in patients with advanced and/or recurrent cervical carcinoma |
| 55892 | Phase II study of high dose Epirubicin in patients with advanced ovarian carcinoma |
| 55891 | Phase II study of etoposide in patients with recurrent or advanced granulosa-theca cell tumor of the ovary |
| 55881 | Phase II trial of Fotemustine (S 100360) in patients with advanced ovarian carcinoma |
| 55882 | PHASE II TRIAL OF FLUTAMIDE IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA. |
| 55872 | Randomized phase II protocol to study adriamycin/Cisplatin in combination and adriamycin alone in patients with advanced and/or recurrent endometrial carcinoma |
| 55874 | Phase III study to evaluate the role of adjuvant radiotherapy in the treatment of uterine sarcomas stages I and II |
| 55875 | Intraperitoneal Cisplatin versus no further treatment: A phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based induction chemotherapy and cytoreductive surgery |
| 55876 | Phase II study of D-TRP-6-LHRH (decapeptyl) in patients with advanced ovarian carcinoma |
| 55871 | Phase II study of bleomycin, Methotrexate and CCNU in locally advanced, radically inoperable squamous cell carcinoma of the vulva |
| 55873 | Randomized phase II protocol to study cyclophosphamide or Ifosfamide in patients with advanced and/or recurrent endometrial carcinoma |
| 55865 | Phase III study for the treatment of ovarian cancer FIGO stages IIB and C, III and IV |
| 55862 | Phase II study of a combination of cis-diammine-dichloro-platinum, vinblastine, and bleomycin in patients with recurrent or advanced dysgerminoma |
| 55856 | Phase II trial for intraperitoneal cisplatin in ovarian cancer FIGO III, IV minimal residual disease after chemotherapy and cytoreductive surgery |
| 55857 | Phase II trial of 5-aza-2'-deoxycytidine in patients with advanced or recurrent squamous cell carcinoma of the uterine cervix |
| 55854 | Phase II Randomized Chemotherapy Trial of CHIP vs CACP in Patients with Advanced Ovarian Cancer Refractory or Recurrent After First-Line Chemotherapy with CBDCA (Summary Last Modified 05/88) |
| 55853 | Phase II trial of carboplatin in advanced/recurrent endometrial carcinoma |
| 55852 | Phase II trial of a combination of Cyclophosphamide, Adriamycin, and Cisplatin (CAP) in advanced tuba carcinoma |
| 55851 | Phase II trial of a combination of vindesine, Cisplatin, bleomycin, and mitomycin-C (BEMP) in disseminated squamous cell carcinoma of the uterine cervix |
| 55843 | Phase II trial of a combination of cis-diammine-dichloro-platinum, vinblastine, and bleomycin in patients with recurrent or advanced granulosa-theca cell tumors of the ovary |
| 55839 | Phase II Chemotherapy with Mitoxantrone for Recurrent and/or Disseminated Endometrial Carcinoma |
| 55012 | A phase III study of Cisplatin plus Topotecan followed by Paclitaxel plus Carboplatin versus Paclitaxel plus Carboplatin as first line chemotherapy in women with newly diagnosed advanced epithelial ovarian cancer. |
| 55985 | PHASE II CLINICAL TRIAL ON TAXOL AS SINGLE AGENT IN LOCALLY ADVANCED AND/OR METASTATIC OR RECURRENT VULVA CANCER NOT AMENABLE FOR SURGERY AND/OR RADIOTHERAPY - EORTC trial 55985 |
| 55955 | A randomised trial in relapsed ovarian cancer: Early treatment based on CA 125 levels alone vs Delayed treatment based on conventional clinical indicators - MRC OV05 and EORTC/GCCG 55955 |
| 55863 | Randomized phase III trial of vindesine, Cisplatin, bleomycin and mitomycin-C (BEMP) versus Cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix |
| 55051 | A multi-national randomized Phase III GCIG Intergroup Study comparing Pegylated Liposomal Doxorubicin and Carboplatin (CaC) versus Paclitaxel and Carboplatin (TC) in patients with epithelial ovarian cancer in late relapse (>6 months). |
| 55991 | A randomized trial of adjuvant treatment with radiation plus chemotherapy versus radiation alone in high risk endometrial carcinoma. |
| 55981 | A randomized trial of Paclitaxel/Epirubicin/Carboplatin Combination (TEC) versus Paclitaxel/Carboplatin (TC) in the treatment of women with Advanced Ovarian Cancer |
| 55971 | Randomized Phase III study comparing upfront debulking surgery versus neo-adjuvant chemotherapy in patients with Stage IIIc or IV epithelial ovarian carcinoma. |
| 55984 | A randomized trial of Adryamicin (A) Cisplatin (P) chemotherapy versus Paclitaxel (T) Adriamycin (A) and Cisplatin (P) in patients with metastatic/relapsed or locally advanced inoperable endometrial cancer. |
| 55041 | A randomized, multicentre, phase III study of Erlotinib versus observation in patients with no evidence of disease progression after first line, platinum-based chemotherapy for high-risk Stage I and Stage II-IV ovarian epithelial, primary peritoneal, or fallopian tube cancer |
| 55994 | Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer. |